• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Fred Pennic, Editor-in Chief | HIT Consultant

Fred Pennic is the Founder and Editor-in-Chief of HIT Consultant.

Innovaccer Appoints Former Kaiser Permanente CTO Mike Sutten as Chief Digital Officer

by Fred Pennic 11/27/2019 Leave a Comment

Innovaccer Appoints Former Kaiser Permanente CTO Mike Sutten as Chief Digital Officer

- Innovaccer appoints Mike Sutten as their new Chief Digital Officer to refine Innovaccer’s strategy to build on the mission of a connected care continuum that ensures patient data is available to providers across the care experience. - Sutten brings more than 25 years of technology leadership with Kaiser Permanente, Fortune 500 organizations and the Central Intelligence Agency. Innovaccer Inc., a healthcare technology company has appointed Mike Sutten as their new Chief Digital Officer to
Read More

Quartet Health, Cambia Health Solutions Partner to Bring AI-Enabled Platform to Cambia’s Members

by Fred Pennic 11/27/2019 Leave a Comment

Centene Leads $60M Round for Behavioral Health Platform Quartet

 - Quartet is partnering with Cambia Health Solutions to bring its AI-enabled platform to Cambia's members so they can get better access to mental healthcare.- Additionally, Echo Health Ventures, a strategic collaboration of Cambia and Mosaic Health Solutions made an investment in Quartet.Today Quartet, a healthcare technology and services company, announced a new partnership with Cambia Health Solutions to help improve the lives of people with mental health conditions. Cambia’s regional health
Read More

The State of Patient Access and Engagement: Consumer Demand Versus Reality

by Fred Pennic 11/27/2019 Leave a Comment

State of Patient Access and Engagement

- DocASAP, a patient access and engagement platform for health systems, health plans and physician groups revealed the findings of its first annual “State of Patient Access and Engagement” survey. - The survey, conducted by OnePoll and commissioned by DocASAP in October 2019, uncovers insights into patients’ preferences, frustrations and expectations when communicating and engaging with health plans and healthcare providers.DocASAP, a provider of the most advanced patient access and engagement
Read More

Eko Unveils Redesigned Smart Stethoscope and Stethoscope Attachment

by Fred Pennic 11/25/2019 Leave a Comment

Eko Unveils Redesigned Smart Stethoscope and Stethoscope Attachment

- Eko unveils the second generation of CORE products, which includes a smart stethoscope and a stethoscope attachment designed to make any existing stethoscope smarter.- The technological advancements of the CORE include active noise cancellation, sleeker design, and powerful software to allow medical professionals to more effectively screen for heart disease.- The CORE Digital Attachment ($199) and the fully assembled CORE Digital Stethoscope ($249) are available for pre-order now to healthcare
Read More

Rad AI Raises $4M to Automate Repetitive Tasks for Radiologists Through Machine Learning

by Fred Pennic 11/25/2019 Leave a Comment

Rad AI Raises $4M to Automate Repetitive Tasks for Radiologists Through Machine Learning

- Rad AI raises $4M in seed funding led by Gradient Ventures, Google’s AI-focused venture fund to transform radiology with the latest advances in AI to save radiologists 60+ minutes a day. - By streamlining existing workflow and automating repetitive manual tasks, Rad AI increases daily productivity while reducing radiologist burnout.  - Rad AI provides more consistent radiology reports for ordering clinicians, and higher accuracy for the patients it serves. Berkeley-based Rad AI, a
Read More

Cone Health Launches Innovation Center to Develop & Launch Ideas

by Fred Pennic 11/25/2019 Leave a Comment

Cone Health Launches Innovation Center to Develop & Launch Ideas

- Cone Health forms an innovation center named Cone Health Ventures to serve as a testing ground for new products and services focused on health and wellness. - Cone Health Ventures will serve as the innovation framework bringing together entrepreneurial insight, healthcare expertise and a human-centered approach to innovation.Cone Health, a Greensboro, NC-based integrated not-for-profit network of providers serving people in central North Carolina has announced the launch of Cone Health
Read More

HMS Holdings Corp to Acquire Payment Accuracy Company Accent for $155M

by Fred Pennic 11/21/2019 Leave a Comment

HMS Holdings Corp to Acquire Payment Accuracy Company Accent for $155M

- HMS Holdings Corp acquires Accent, a payment accuracy, and cost containment business from Intrado Corporation for approximately $155 million.- Accent’s offerings include comprehensive prospective and retrospective claims accuracy solutions, which incorporates both cost avoidance and overpayment recovery services.- Addition of service provider to commercial and Medicare Advantage health plans to expand the breadth of HMS’ prospective and retrospective claims accuracy services.HMS Holdings Corp.
Read More

Presidium Health Raises $3.5M to Expand On-Demand Care Platform

by Fred Pennic 11/21/2019 Leave a Comment

Presidium Health Raises $3.5M to Expand On-Demand Care Platform

- Presidium Health raises $3.5M to expand optimized in-home medical services based on geo-proximity to the medically complex and underserved population utilizing a home-based model of careThe company's flagship platform, STAT (Secure Text Activated Triage) is a simple user interface that provides patients with a medical alert device that allows for two-way communication, real-time transmission of vitals and personal health records to a HIPAA-compliant text platformPresidium Health, a San Diego,
Read More

GenapSys Nabs $90M to Commercialize Its Breakthrough Electronic Gene Sequencer

by Fred Pennic 11/20/2019 Leave a Comment

- GenapSys launches their first-of-its-kind electronic gene sequencer as well as the completion of a $90M series C funding round led by top biotech investor Foresite Capital. - GenapSys is the first & only to use direct electronic sequencing -- this allows for a simpler workflow, dramatically reduced costs, turnaround time and device size. - The GenapSys Sequencer is exceptionally accurate and 100x smaller and more affordable than current high-throughput sequencers and will significantly expand access to genetic health insights. GenapSys Inc. announced today that it has completed a $90 million funding round, led by Foresite Capital to commercialize the smallest and most affordable highly accurate sequencer ever developed. Now available for purchase, the device uses first-of-its-kind technology to deliver results at a fraction of the cost of legacy technologies, while still delivering highly accurate results. This latest investment round brings the company’s total funding to $166M to date. The new capital will be used to drive the commercial launch of the company’s first-generation product, grow GenapSys’ interdisciplinary team, and empower continued innovation. Accessible Sequencing Holds the Key to Innovation In 2019, 10 million people will die of cancer. And, yet, only 3 percent of cancer drugs tested in clinical trials since 2000 have been approved for patient use and not a single one offers a cure. Gene sequencing maybe the answer. By analyzing every component of our DNA, gene sequencing allows doctors and scientists to more effectively diagnose disease and develop better treatments. Beyond cancer, sequencing has the potential to supercharge everything from reproductive health to pathogen testing. But a single sequencing device typically costs up to $1M, limiting its reach and acting as a major bottleneck to advancement in healthcare. A Breakthrough in Sequencing with High Accuracy and Low Cost GenapSys is the first & only to use direct electronic sequencing -- this allows for a simpler workflow, dramatically reduced costs, turnaround time and device size miniaturized to the size of an iPad. It's up to 100x smaller and less expensive at under $10,000 than legacy sequencing technologies, while redefining the gold standard with over 99.9% accuracy. In other words, similar to the iPhone, sequencing will be taken to the size of a mobile device and made affordable to nearly any institution. For the $46B genomics market previously dominated by much more expensive device companies like Illumina, this could transform healthcare as we know it. Unlike many others on the market, GenapSys achieves gold standard accuracy while maintaining low costs and portability. An independent study conducted by The Jackson Laboratory, a leading global nonprofit biomedical research institution, found that GenapSys sequencers deliver consistent and excellent performance across a variety of biological samples. Recently at American Society of Human Genetics in Houston, The Jackson Laboratory presented the results of their study which found that the GenapSys sequencers are superior to optical detection methods in detecting single nucleotide mutations, a critical task used for cancer and inherited disease detection. Availability The GenapSys sequencer has been tested extensively across leading genomics labs across the nation. All studies thus far have indicated exceptional performance; published work is publicly available on BioRxiv. The GenapSys Sequencer is currently available for order in the U.S. with global sales beginning in early 2020. “We are entering a multi-decade era of genomics that will revolutionize many industries, including healthcare diagnostics, pharmaceutical discovery, personalized medicine, food testing, forensics, agriculture, biology and beyond - but until now, we’ve lacked the access necessary to realize this potential,” explained Dr. Hesaam Esfandyarpour, CEO and founder of GenapSys. “With our new sequencer, we can rapidly enable and scale genomics power to every researcher, physician, provider, and patient around the world.”

- GenapSys launches first-of-its-kind electronic gene sequencer as well as the completion of a $90M series C funding round led by top biotech investor Foresite Capital.  - GenapSys is the first & only to use direct electronic sequencing -- this allows for a simpler workflow, dramatically reduced costs, turnaround time and device size.- The GenapSys Sequencer is exceptionally accurate and 100x smaller and more affordable than current high-throughput sequencers and will significantly expand
Read More

Geisinger, Medial EarlySign Advances to First Stage of CMS AI Health Outcomes Challenge

by Fred Pennic 11/20/2019 Leave a Comment

Clinical Operations Makes Highest Use of Artificial Intelligence, Tufts Study Finds

- Geisinger Health was recently named by the Centers for Medicare & Medicaid Services among the 25 candidates advancing to the first stage of its AI Health Outcomes challenge.- The CMS AI Health Outcomes challenge provides innovators with the opportunity to demonstrate how AI tools may be implemented to predict health outcomes and keep patients healthy in hopes of more AI tools being considered for potential use in CMS Innovation Center payment and service delivery models. Geisinger, an
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 389
  • Go to page 390
  • Go to page 391
  • Go to page 392
  • Go to page 393
  • Interim pages omitted …
  • Go to page 475
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |